<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Roche> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/2004/02/skos/core#altLabel>	"bevacizumab (Avastin)" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Monoclonal_antibody> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Combined_small-cell_lung_carcinoma> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Monoclonal_antibody_for_tumors> .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/fdaUniiCode>	"2S9ZZM9Q9V" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Orphan_drug> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Genentech_brands> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Therapeutic_monoclonal_antibody> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Genentech_brand> .
<http://caligraph.org/resource/Genentech>	<http://caligraph.org/ontology/product>	<http://caligraph.org/resource/Bevacizumab> .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/casNumber>	"216974-75-3" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/2004/02/skos/core#altLabel>	"Avastin" .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/kegg>	"D06409" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Timeline_of_cancer_treatment_development> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Drug:_Be> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Targeted_therapy> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Specialty_drug> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_drugs_by_year_of_discovery> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_drugs:_Be> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Protein_kinase_inhibitor> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/World_Health_Organization_essential_medicine> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_drugs_known_for_off-label_use> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Targeted_therapy_of_lung_cancer> .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/alternativeName>	"Avastin, others" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/2004/02/skos/core#altLabel>	"Avastin and Altuzan" .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/drugbank>	"DB00112" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Side_effect> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Biosimilar> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Angiogenesis_inhibitor> .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/chEMBL>	"1201583" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Renal_cell_carcinoma> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Largest_selling_pharmaceutical_product> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_largest_selling_pharmaceutical_products> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Drug_granted_breakthrough_therapy_designation> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Orphan_drugs> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Cancer_pain> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Ophthalmology_drugs> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Chemotherapy> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Gholam_A._Peyman> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/2000/01/rdf-schema#label>	"Bevacizumab" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/2002/07/owl#sameAs>	<http://dbpedia.org/resource/Bevacizumab> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/2004/02/skos/core#altLabel>	"bevacizumab" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Thrombotic_thrombocytopenic_purpura> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Anti%E2%80%93vascular_endothelial_growth_factor_therapy> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Receptor_tyrosine_kinase> .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/bioavailability>	"100.0" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy> .
<http://caligraph.org/resource/Cystadenocarcinoma>	<http://caligraph.org/ontology/medication>	<http://caligraph.org/resource/Bevacizumab> .
<http://caligraph.org/resource/Bevacizumab>	<http://caligraph.org/ontology/medlinePlus>	"a607001" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Retinopathy_of_prematurity> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Genentech> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Hoffmann-La_Roche_brand> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Ophthalmology_drug> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Specialty_drugs> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_antineoplastic_agents> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Bevacizumab" .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies_for_tumors> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Antineoplastic_agent> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Drug_known_for_off-label_use> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Fine_chemical> .
<http://caligraph.org/resource/Bevacizumab>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Angiogenesis_inhibitors> .